A recent study reveals that individuals who stop using new weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who halt conventional diet and exercise regimens.
Published data in a leading health publication demonstrates that while obese people frequently drop substantial amounts of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users buying these treatments need to be informed of the danger of quick weight regain when the treatment ends," stated researcher Dr. Susan Jebb.
Such speed of recovery means a return to starting mass within about 18 months.
Analyzing Therapies
The study, which examined dozens of studies involving thousands of patients, compared the effects of GLP-1 agonists with conventional dieting.
Researchers emphasize that individuals who shed pounds through diet and exercise typically have a less rapid weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Doctors believe the mechanism of the injections is key to understanding the heightened weight return.
These medications mimic a body's own chemical called GLP-1, which helps regulate hunger.
"Sustained high doses of the hormone levels far above than normal may cause the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to appetite is uncontrolled, making excessive eating far more likely."
A Lifelong Disease?
Health authorities advise the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts contend that, considering the likelihood of relapse, the treatment might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who state that the findings "highlight the long-term nature of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
Users who have come off the medication describe a powerful resurgence of cravings.
"I experienced something flipping and you become extremely hungry," described an individual.
The struggle is compounded if patients have not established lasting lifestyle or habit modifications during treatment.
Significant Interest
Figures show that a significant number of people in the UK have used weight-loss jabs in the past year, with interest being substantial.
- Adoption is greater among females compared to men.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, clinicians emphasize that while these medications are potent agents for shedding pounds, they are not a magic solution and maintained weight loss hinges on ongoing behavioural management.
